Lv3
350 积分 2024-05-09 加入
Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development
21天前
已完结
Retrospective Analysis of Bioanalytical Method Validation Approaches in Biosimilar Biological Product Development
21天前
已完结
Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approach
22天前
已完结
Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approach
22天前
已关闭
Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approach
22天前
已关闭
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs
22天前
已完结
Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab
25天前
已完结
〈1106〉 Immunogenicity Assays—Design and Validation of Immunoassays to Detect Anti-Drug Antibodies
25天前
已关闭
Statistical Evaluation of Several Methods for Cut-Point Determination of Immunogenicity Screening Assay
25天前
已完结
Development of an ELISA with acidification treatment for an antibody conjugate incorporating Exatecans
29天前
已完结
皖公网安备34019202002308
